Kopran Limited, a fully integrated pharmaceutical company, manufactures and markets active pharmaceutical ingredients and finished dosage forms both in India and globally. The company offers a wide range of products in various forms such as tablets, capsules, syrups, dry powder, suspension, injectables, and topical preparations. Additionally, Kopran Limited specializes in producing drugs across multiple therapeutic categories including macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. Moreover, the company also provides medications for erectile dysfunction, antiallergics, respiratory ailments, oncology, central nervous system disorders, antiprotozoal infections, anthelmintics, antipeptic ulcer and gut disorders, and other medical conditions. Established in 1958, Kopran Limited is headquartered in Mumbai, India.
Navigation section
Kopran Limited
- 211.10 -2.97(-1.39%) 212.70 -3.60(-1.66%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 210.00 209.00 | 217.89 220.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 198.00 (21-Nov-2024) 198.05 (21-Nov-2024) | 369.70 (09-Sep-2024) 369.20 (09-Sep-2024) |
- Open
- 217.89 216.50
- Previous Close
- 214.07 216.30
- Volume
- 1.38
- Total Traded value
- 2.94 (₹ Lakhs)
- Upper circuit
- 224.77 325.60
- Lower circuit
- 203.36 217.10
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 506 | 0 |
| Bid Price | Quantity |
|---|---|
| 211.53 | 506.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 506 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹10.19 Cr |
| PE Ratio (TTM): | 30.08 |
| PB Ratio: | 2.50 |
| Industry P/E: | 19.53 |
| Debt to Equity: | - |
| ROE: | 8.32 |
| EPS (TTM): | 7.19 |
| Book Value: | 81.05 |
| Face Value: | 10.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 98.64 Cr | 65.86 Cr | 80.23 Cr | 67.96 Cr | 53.62 Cr |
| Profit | 10.66 Cr | 0.15 Cr | 5.52 Cr | 4.04 Cr | 17.89 Cr |
| Expense | 91.84 Cr | 65.81 Cr | 74.79 Cr | 63.70 Cr | 49.46 Cr |
| Comprehensive income | 10.68 Cr | 0.17 Cr | 5.50 Cr | 4.08 Cr | 17.92 Cr |
| EPS | 2.20 | 0.03 | 1.14 | 0.84 | 3.71 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Kopran Limited | Jun, 1999 Mar, 1993 | Pharmaceuticals Pharmaceuticals | KOPRAN KOPRAN |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Kopran Limited FAQ's
What is the range of today's stock performance for Kopran Limited?
Today's stock performance witnessed a fluctuation from a minimum of 210.00 on the NSE (National Stock Exchange) to a maximum of 217.89. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 209.00 to a high of 220.00.
What are the 52-week low and high values for Kopran Limited?
The stock's performance over the past 52 weeks reveals a low of 198.00 (occurred on 21-Nov-2024) and a high of 369.70 (achieved on 09-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 198.05 (on 21-Nov-2024), and the 52-week high is 369.20 (on 09-Sep-2024).
What was the opening and previous closing prices for Kopran Limited?
The stock's performance over the past 52 weeks reveals a low of 198.00 (occurred on 21-Nov-2024) and a high of 369.70 (achieved on 09-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 198.05 (on 21-Nov-2024), and the 52-week high is 369.20 (on 09-Sep-2024).
What is the total volume and traded value for Kopran Limited for the day?
The total volume is 1, and the total traded value is 2.94 (₹ Lakhs).
What are the upper and lower circuit limits for Kopran Limited?
The upper circuit limit is 224.77, and the lower circuit limit is 203.36.
What is the market cap and PE ratio for Kopran Limited?
The market cap is ₹10.19 Cr, and the PE ratio (TTM) is 19.53.
What is the PB ratio, industry P/E, and debt to equity ratio for Kopran Limited?
The PB ratio is 2.60, industry P/E is 19.53 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Kopran Limited?
ROE is 8.32, EPS is 7.19, book value is 81.05
What are the revenue and profit figures for the latest quarter and previous quarters for Kopran Limited?
In Sep 2023, Revenue is ₹986388000.00, and Profit is ₹106631000.00. In Jun 2023, Revenue is ₹658600000.00, and Profit is ₹1534000.00.
When was Kopran Limited listed, and what industry does it belong to?
The company, Kopran Limited, was listed in Jun 1999 and belongs to the Pharmaceuticals industry. Its NSE symbol is KOPRAN.
What is the current shareholding pattern of the Kopran Limited?
As of latest available update, promoters hold 44.49%, the public holds 55.51%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
